
To investigate the safety, zzso and short-term efficacy of treatment with zzso in patients with zzso zzso as a first zzso zzso 

We conducted this zzso zzso pilot study in the zzso University of Medical Sciences, zzso Iran, from March 2007 to January zzso The participants were patients aged zzso years with zzso zzso and at least 3 zzso zzso on zzso and zzso zzso but no clinically zzso multiple sclerosis zzso They were zzso into 2 zzso The case group (5 zzso received intravenous zzso zzso zzso zzso zzso and intravenous zzso zzso zzso zzso for 5 consecutive days, and the control group (5 zzso received intravenous zzso zzso at the same dose as the case group, and a zzso The groups were followed for one year and compared for adherence to zzso adverse drug effects, mean duration of conversion to clinically zzso zzso and zzso zzso 

All patients tolerated the zzso One patient who received zzso developed cerebral zzso zzso zzso and zzso zzso zzso One patient in the control group, but no patients in the case group, fulfilled the McDonald criteria for zzso during the follow-up period, but none of the participants in either group developed clinically zzso zzso according to the zzso zzso 

zzso may be effective, but should be used with zzso 

